Latest Blog Posts Tagged "Research News"
February 14, 2019
MJFF partners in the Australian Parkinson's Mission to support clinical trials of repurposed therapies that could slow the progression of the disease.
February 13, 2019
Listen to Dr. Rachel Dolhun tackle widespread myths about levodopa.
February 07, 2019
Levodopa is the most effective Parkinson's medication, but there are many misconceptions about what this drug can and can't do. In this video, Dr. Dolhun discusses the facts about levodopa.
February 05, 2019
Members of our Patient Council discuss their role in choosing eight innovative projects we're now funding to treat gait and balance problems.
The Michael J. Fox Foundation for Parkinson's Research Awards $3 Million To Develop New Technologies for Gait & Balance Issues in Parkinson's
February 04, 2019
The eight new awards support novel technologies with the potential to significantly improve people's daily lives.
January 31, 2019
The U.S. Food and Drug Administration requested more analyses of a thin film of apomorphine to relieve symptoms when medication is not working optimally.
January 30, 2019
MJFF is prioritizing research into exactly how inflammation affects the brain and how we might treat it.
'How can we all, who have a common interest, come together:' 23andMe and MJFF Collaborate to Further Parkinson's Research
January 28, 2019
MJFF and 23andMe are currently collaborating through Fox Insight, MJFF's online clinical study.
January 25, 2019
New research on levodopa, the most commonly prescribed Parkinson's medication, confirms that the drug neither speeds nor delays disease progression.
January 23, 2019
Want to learn more about Fox Insight, The Michael J. Fox Foundation's online clinical study?